Sarepta Says Another Patient Died After Receiving Gene Therapy Bloomberg Patient dies in Sarepta gene therapy trial, adding to safety concerns STAT Sarepta Therapeutics lays off one-third of workforce in drastic cost-cutting The Boston Globe Third death from a Sarepta gene therapy BioCentury Sarepta Therapeutics Stock Is Surging After The Bell: What’s Going On? Yahoo Finance Source link
Read More »